{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:41:18Z","timestamp":1786372878374,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2018,9]]},"abstract":"\n Background and objectives<\/jats:title>\n \n Infections caused by multidrug-resistant organisms and\n Clostridium difficile<\/jats:italic>\n are associated with substantial morbidity and mortality as well as excess costs. Antimicrobial exposure is the leading cause for these infections. Approximately 30% of antimicrobial doses administered in outpatient hemodialysis facilities are considered unnecessary. Implementing an antimicrobial stewardship program in outpatient hemodialysis facilities aimed at improving prescribing practices would have important clinical and economic benefits.\n <\/jats:p>\n <\/jats:sec>\n \n Design, setting, participants, & measurements<\/jats:title>\n \n We developed a decision analytic model of antimicrobial use on the clinical and economic consequences of implementing a nationwide antimicrobial stewardship program in outpatient dialysis facilities. The main outcomes were total antimicrobial use, infections caused by multidrug-resistant organisms and\n C. difficile<\/jats:italic>\n , infection-related mortality, and total costs. The analysis considered all patients on outpatient hemodialysis in the United States. The value of implementing antimicrobial stewardship programs, assuming a 20% decrease in unnecessary antimicrobial doses, was calculated as the incremental differences in clinical end points and cost outcomes. Event probabilities, antimicrobial regimens, and health care costs were informed by publicly available sources.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n On a national level, implementation of antimicrobial stewardship programs was predicted to result in 2182 fewer infections caused by multidrug-resistant organisms and\n C. difficile<\/jats:italic>\n (4.8% reduction), 629 fewer infection-related deaths (4.6% reduction), and a cost savings of $106,893,517 (5.0% reduction) per year. The model was most sensitive to clinical parameters as opposed to antimicrobial costs.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n \n The model suggests that implementation of antimicrobial stewardship programs in outpatient dialysis facilities would result in substantial reductions in infections caused by multidrug-resistant organisms and\n C. difficile<\/jats:italic>\n , infection-related deaths, and costs.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.2215\/cjn.12521117","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T09:55:31Z","timestamp":1535018131000},"page":"1389-1397","source":"Crossref","is-referenced-by-count":24,"title":["Clinical and Economic Benefits of Antimicrobial Stewardship Programs in Hemodialysis Facilities"],"prefix":"10.2215","volume":"13","author":[{"given":"Erika M.C.","family":"D\u2019Agata","sequence":"first","affiliation":[{"name":"Divisions of Infectious Diseases and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Tran","sequence":"additional","affiliation":[{"name":"Cornerstone Research Group, Burlington, Ontario, Canada; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Bautista","sequence":"additional","affiliation":[{"name":"Hypertension and Nephrology Inc., Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Shemin","sequence":"additional","affiliation":[{"name":"Nephrology, Rhode Island Hospital, Brown University, Providence, Rhode Island;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Grima","sequence":"additional","affiliation":[{"name":"Cornerstone Research Group, Burlington, Ontario, Canada; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2018,8,23]]},"reference":[{"key":"B1-20230813","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.2013091028","article-title":"Meta-analysis of methicillin-resistant Staphylococcus aureus colonization and risk of infection in dialysis patients.","volume":"25","author":"Zacharioudakis","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B2-20230813","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.ajkd.2014.05.016","article-title":"Vancomycin-resistant enterococci colonization among dialysis patients: A meta-analysis of prevalence, risk factors, and significance.","volume":"65","author":"Zacharioudakis","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"B3-20230813","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2215\/CJN.04651107","article-title":"Multidrug-resistant gram-negative bacteria among patients who require chronic hemodialysis.","volume":"3","author":"Pop-Vicas","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"B4-20230813","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/MNH.0b013e328350089b","article-title":"Novel antimicrobial-resistant bacteria among patients requiring chronic hemodialysis.","volume":"21","author":"Snyder","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B5-20230813","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/430909","article-title":"Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: A meta-analysis.","volume":"41","author":"DiazGranados","year":"2005","journal-title":"Clin Infect Dis"},{"key":"B6-20230813","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1086\/648448","article-title":"Clostridium difficile infections in outpatient dialysis cohort.","volume":"31","author":"Sheth","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"B7-20230813","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1086\/669869","article-title":"Antimicrobial use in outpatient hemodialysis units.","volume":"34","author":"Snyder","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"B8-20230813","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1086\/605924","article-title":"Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: A randomized controlled trial.","volume":"30","author":"Camins","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"B9-20230813","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1445-5994.2012.02809.x","article-title":"Point-prevalence study of inappropriate antibiotic use at a tertiary Australian hospital.","volume":"42","author":"Ingram","year":"2012","journal-title":"Intern Med J"},{"key":"B10-20230813","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/jhm.1964","article-title":"Antimicrobial use in the ICU: Indications and accuracy--an observational trial.","volume":"7","author":"Levin","year":"2012","journal-title":"J Hosp Med"},{"key":"B11-20230813","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/INF.0b013e3181b12484","article-title":"Antibiotic use in neonatal intensive care units and adherence with Centers for Disease Control and Prevention 12 Step Campaign to Prevent Antimicrobial Resistance.","volume":"28","author":"Patel","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"B12-20230813","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","article-title":"Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.","volume":"44","author":"Dellit","year":"2007","journal-title":"Clin Infect Dis"},{"key":"B13-20230813","first-page":"194","article-title":"Vital signs: Improving antibiotic use among hospitalized patients.","volume":"63","author":"Fridkin","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B14-20230813","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1128\/AAC.00825-16","article-title":"Systematic review and meat-analysis of clinical and economic outcomes from the implementation of hospital-based antimicrobials stewardship programs.","volume":"60","author":"Karanika","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"B17-20230813","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1086\/526530","article-title":"Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients.","volume":"46","author":"Dubberke","year":"2008","journal-title":"Clin Infect Dis"},{"key":"B19-20230813","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1086\/649020","article-title":"Attributable costs of enterococcal bloodstream infections in a nonsurgical hospital cohort.","volume":"31","author":"Butler","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"B20-20230813","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/jama.282.18.1745","article-title":"Control of endemic methicillin-resistant Staphylococcus aureus: A cost-benefit analysis in an intensive care unit.","volume":"282","author":"Chaix","year":"1999","journal-title":"JAMA"},{"key":"B21-20230813","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1086\/502580","article-title":"Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis.","volume":"26","author":"Engemann","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"B22-20230813","doi-asserted-by":"crossref","first-page":"f7450","DOI":"10.1136\/bmj.f7450","article-title":"Converting an odds ratio to a range of plausible relative risks for better communication of research findings.","volume":"348","author":"Grant","year":"2014","journal-title":"BMJ"},{"key":"B25-20230813","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1086\/678592","article-title":"Guidance for the knowledge and skills required for antimicrobial stewardship leaders.","volume":"35","author":"Cosgrove","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"B26-20230813","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/cid\/ciw217","article-title":"Executive summary: Implementing an antibiotic stewardship program: Guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America.","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"B27-20230813","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/MNH.0000000000000281","article-title":"Antimicrobial stewardship in out-patient dialysis units.","volume":"25","author":"Cunha","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B28-20230813","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/1471-2334-11-279","article-title":"Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.","volume":"11","author":"Schweizer","year":"2011","journal-title":"BMC Infect Dis"},{"key":"B29-20230813","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1086\/510386","article-title":"Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia.","volume":"44","author":"Stryjewski","year":"2007","journal-title":"Clin Infect Dis"},{"key":"B30-20230813","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1681\/ASN.2012010050","article-title":"Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD.","volume":"23","author":"Chan","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B31-20230813","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 Update by the infectious diseases society of America.","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"B32-20230813","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jpeds.2015.09.025","article-title":"A cost-effectiveness analysis of obtaining blood cultures in children hospitalized for community-acquired pneumonia.","volume":"167","author":"Andrews","year":"2015","journal-title":"J Pediatr"},{"key":"B33-20230813","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.clinthera.2015.03.021","article-title":"Economic comparison of an empirical versus diagnostic-driven strategy for treating invasive fungal disease in immunocompromised patients.","volume":"37","author":"Barnes","year":"2015","journal-title":"Clin Ther"},{"key":"B34-20230813","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/j.ajic.2015.05.033","article-title":"Empirical therapies among adults hospitalized for community-acquired upper urinary tract infections: A decision-tree analysis of mortality, costs, and resistance.","volume":"43","author":"Parienti","year":"2015","journal-title":"Am J Infect Control"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201809000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:38:34Z","timestamp":1786369114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201809000-00014"}},"subtitle":["A Decision Analytic Model"],"short-title":[],"issued":{"date-parts":[[2018,8,23]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.12521117","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,23]]}}}